Recent HIV-1 infection: To treat or not to treat, that is the question

Journal of Infectious Diseases

Volumn 205, Issue 1, 2012, Pages 10-12

  Tossonian, Harout ^a   Conway, Brian ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; LOPINAVIR PLUS RITONAVIR; ZIDOVUDINE;

ANTIBODY RESPONSE; CD4 LYMPHOCYTE COUNT; CLINICAL FEATURE; CLINICAL OBSERVATION; CLINICAL TRIAL (TOPIC); DRUG EFFICACY; DRUG EXPOSURE; DRUG SAFETY; EMPOWERMENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV EDUCATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NOTE; OUTCOME ASSESSMENT; PATIENT EDUCATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT DURATION; TREATMENT RESPONSE; VIRUS DETECTION; VIRUS LOAD; VIRUS TRANSMISSION;

ADENINE; ANTI-HIV AGENTS; DEOXYCYTIDINE; DRUG COMBINATIONS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LOPINAVIR; MALE; PHOSPHONIC ACIDS; RITONAVIR; VIRAL LOAD;

EID: 84555187489     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir702     Document Type: Note

References (13)

1. Cooper DA, Gold J, Maclean P, et al. Acute AIDS retrovirus infection: definition of a clinical illness associated with seroconversion. Lancet 1985; 1:537-40. (Pubitemid 15101846)
2. Montessori V, Rouleau D, Raboud J, et al. Clinical characteristics of primary HIV infection in injection drug users. AIDS 2000; 14:1868-70.
3. Pilcher CD, Eron JJ Jr, Galvin S, Gay C, Cohen MS. Acute HIV revisited: new opportunities for treatment and prevention. J Clin Invest 2004; 113:937-45. (Pubitemid 38544111)
4. Kinloch-de Loës S, Hirschel BJ, Hoen B, et al. A controlled trial of zidovudine in primary human immunodeficiency virus infection. N Engl J Med 1995; 333:408-13.
5. Ho DD. Time to hit HIV, early and hard. N Engl J Med 1995; 333:450-1.
6. Rosenberg ES, Altfeld M, Poon SH, et al. Immune control of HIV-1 after early treatment of acute infection. Nature 2000; 407:523-6.
7. Lampe FC, Porter K, Caldor J, Law M, Kinloch-de Loës S, Phillips AN. Effect of transient antiretroviral treatment during acute HIV infection: comparison of the Quest trial results with CASCADE natural history study. Antivir Ther 2007; 12:189-93. (Pubitemid 46569904)
8. Department of Health and Human Services. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Washington, DC: Department of Health and Human Services, 2011:91. www.aidsinfo. nih.gov/contentfiles/AdultandAdolescentGL. pdf. Accessed 2 November 2011.
9. Hogan C, DeGruttola V, Sun X, et al. The Setpoint Study (ACTG A5217)-Effect of immediate versus deferred antiretroviral therapy on virologic setpoint in recently HIV-1-infected individuals. J Infect Dis 2011; 205:87-96.
10. Fidler S, SPARTAC trial investigators. The effect of short-course antiretroviral therapy in primary HIV infection: final results from an international randomized controlled trial; SPARTAC [abstract WELBX06]. In: Program and abstract of the Sixth International AIDS Society Conference on HIV Pathogenesis, Treatment & Prevention (Rome). Geneva: IAS, 2011.
11. Cohen MS, Shaw GM, McMichael AJ, Haynes BF. Acute HIV-1 infection. N Engl J Med 2011; 364:1943-54.
12. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365:493-505.
13. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. N Engl J Med 2000; 342:921-9. (Pubitemid 30177052)